These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 38042057)

  • 1. Corrigendum to "Altered levels of fecal short-chain fatty acids are associated with subclinical inflammation and worse cognitive performance in patients with schizophrenia" [J. Psychiatr. Res. 165 (2023) 298-304].
    Kowalski K; Szponar B; Bochen P; Żebrowska-Różańska P; Łaczmański Ł; Samochowiec J; Misiak B
    J Psychiatr Res; 2024 Jan; 169():191. PubMed ID: 38042057
    [No Abstract]   [Full Text] [Related]  

  • 2. Altered levels of fecal short-chain fatty acids are associated with subclinical inflammation and worse cognitive performance in patients with schizophrenia.
    Kowalski K; Szponar B; Bochen P; Żebrowska-Różańska P; Łaczmański Ł; Samochowiec J; Misiak B
    J Psychiatr Res; 2023 Sep; 165():298-304. PubMed ID: 37552919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials" [J. Psychiatr. Res. 103 (2018) 244-251].
    Zheng W; Cai DB; Yang XH; Li L; Zhang QE; Ng CH; Ungvari GS; Li XB; Ning YP; Xiang YT
    J Psychiatr Res; 2018 Oct; 105():54. PubMed ID: 30149220
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Development and validation of the Social Touch Experiences and Attitudes Questionnaire-Chinese version (STEAQ-C): How interpersonal touch relates to subclinical traits and symptoms" [J. Psychiatr. Res. 178 (2024) 114-124].
    Zhou HY; Su PX; Cai YQ
    J Psychiatr Res; 2024 Nov; 179():44. PubMed ID: 39241410
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Schizophrenia and co-morbidity risk: Evidence from a data driven phenomewide association study" [J. Psychiatr. Res. 162 (2023) 1-10].
    Mulugeta A; Suppiah V; Hyppönen E
    J Psychiatr Res; 2023 Sep; 165():344. PubMed ID: 37579681
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Effect of lurasidone vs olanzapine on neurotrophic biomarkers in unmedicated schizophrenia: A randomized controlled trial" [J. Psychiatr. Res. 112 (2019) 1-6].
    Jena M; Ranjan R; Mishra BR; Mishra A; Nath S; Sahu P; Meher BR; Srinivasan A; Maiti R
    J Psychiatr Res; 2020 Jul; 126():141. PubMed ID: 31831143
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Bidirectional longitudinal associations of omega-3 polyunsaturated fatty acid plasma levels with depressive disorders" [J. Psychiatr. Res. 124 2020, 1-8].
    Thesing CS; Bot M; Milaneschi Y; Giltay EJ; Penninx BWJH
    J Psychiatr Res; 2020 Jul; 126():112-113. PubMed ID: 32446109
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Impaired socio-affective, but intact socio-cognitive skills in patients with treatment-resistant, recurrent depression" [J. Psychiatr. Res. 153 (2022) 206-212 / https://doi.org/10.1016/j.jpsychires.2022.07.025].
    Kilian HM; Schiller B; Schläpfer TE; Heinrichs M
    J Psychiatr Res; 2024 Apr; 172():198-199. PubMed ID: 38401364
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Investigations of motor-cortex cortical plasticity following facilitatory and inhibitory transcranial theta-burst stimulation in schizophrenia: A proof-of-concept study" [J. Psychiatr. Res. 61 (2015 Feb) 196-204].
    Hasan A; Brinkmann C; Strube W; Palm U; Malchow B; Rothwell JC; Falkai P; Wobrock T
    J Psychiatr Res; 2016 Sep; 80():1-2. PubMed ID: 27499423
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Cognitive trajectories during and after electroconvulsive therapy in patients with MDE: Taking different perspectives" [J. Psychiatr. Res. 152 (2022) 132-140].
    Hebbrecht K; Dejaeger M; Giltay EJ; Birkenhäger T; Sabbe B; Verwijk E; Obbels J; Schrijvers D; Van Diermen L
    J Psychiatr Res; 2023 Feb; 158():41. PubMed ID: 36565543
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Neuropsychiatric symptoms influence differently cognitive decline in older women and men" [J. Psychiatr. Res. 154 (2022) 1-9].
    Ronat L; Monchi O; Hanganu A;
    J Psychiatr Res; 2023 May; 161():476. PubMed ID: 37062108
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials" [J. Psychiatr. Res. 155 (2022) 371-379].
    Qin M; Wu J; Zhou Q; Liang Z; Su Y
    J Psychiatr Res; 2022 Dec; 156():44. PubMed ID: 36242942
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Can machine learning be useful as a screening tool for depression in primary care?" [J. Psychiatr. Res. 2021 Jan; 132:1-6. doi: 10.1016/j.jpsychires.2020.09.025].
    Marques de Souza Filho E; Veiga Rey HC; Frajtag RM; Arrowsmith Cook DM; Dalbonio de Carvalho LN; Pinho Ribeiro AL; Amaral J
    J Psychiatr Res; 2022 Apr; 148():61-62. PubMed ID: 35121269
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to"Ketamine metabolite pilot study in a suicidal depression trial" [J Psychiatr Res 117 (2019) 129-134. doi: 10.1016/j.jpsychires.2019.08.005. Epub 2019 Aug 9].
    Grunebaum MF; Galfalvy HC; Choo TH; Parris MS; Burke AK; Suckow RF; Cooper TB; Mann JJ
    J Psychiatr Res; 2019 Dec; 119():32. PubMed ID: 31550622
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to: "Is pain empathy associated with pain indices and trauma history? A comparison between patients receiving methadone maintenance treatment and healthy controls" [J. Psychiatr. Res. 171 (2024) 286-295 37].
    Zorani S; Peles E
    J Psychiatr Res; 2024 Apr; 172():197. PubMed ID: 38401363
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients" [J. Psychiatr. Res. 123 (2020) 1-8].
    Basso L; Bönke L; Aust S; Gärtner M; Heuser-Collier I; Otte C; Wingenfeld K; Bajbouj M; Grimm S
    J Psychiatr Res; 2020 May; 124():143. PubMed ID: 32155477
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Learning from gain and loss: Links to suicide risk" [J. Psychiatr. Res. 147 (2022) 126-134].
    Dixon-Gordon KL; Waite EE; Ammerman BA; Haliczer LA; Boudreaux ED; Rathlev N; Cohen AL
    J Psychiatr Res; 2022 May; 149():265. PubMed ID: 35305379
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome" [J. Psychiatr. Res. 92 (2017) 124-131].
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2019 Nov; 118():8. PubMed ID: 31445317
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Prediction of suicide among 372,813 individuals under medical check-up" [J. Psychiatr. Res. 131 (2020) 9-14].
    Cho SE; Geem ZW; Na KS
    J Psychiatr Res; 2021 Mar; 135():152. PubMed ID: 33486163
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Sons and parental cognition in mid-life and older adulthood" [J. Psychiatr. Res. 156 (2022) 284-290].
    Wolfova K; Wu D; Weiss J; Cermakova P; Kohler HP; Skirbekk VF; Stern Y; Gemmill A; Tom SE
    J Psychiatr Res; 2023 Apr; 160():8. PubMed ID: 36764196
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.